Sanofi

Sanofi, headquartered in France and operating in Pharmaceutical Preparation Manufacturing, has set ambitious climate commitments and reports comprehensive carbon emissions data.

For the most recent year available, 2025, Sanofi's total carbon emissions are projected to be approximately 4.45 billion kg CO2e. This includes Scope 1 emissions of about 235 million kg CO2e, Scope 2 market-based emissions of approximately 70 million kg CO2e (or 250 million kg CO2e location-based), and Scope 3 emissions of roughly 3.44 billion kg CO2e. Key categories within Scope 3 include purchased goods and services (about 2.39 billion kg CO2e), investments (about 480 million kg CO2e), and capital goods (about 380 million kg CO2e).

Looking back, in 2024, the company's total emissions were approximately 4.66 billion kg CO2e, with Scope 1 at roughly 299 million kg CO2e, Scope 2 market-based at about 76 million kg CO2e, and Scope 3 at around 3.5 billion kg CO2e. In 2023, total emissions stood at approximately 4.8 billion kg CO2e, comprising around 288 million kg CO2e from Scope 1, about 83 million kg CO2e from Scope 2 (market-based), and approximately 3.79 billion kg CO2e from Scope 3.

Sanofi has established several climate commitments, including validated Science Based Targets initiative (SBTi) targets. The company commits to reaching net-zero GHG emissions across its value chain by FY2045 from a FY2019 base year. Near-term, Sanofi aims to reduce absolute Scope 1 and 2 GHG emissions by 55% by FY2030 from a FY2019 baseline. Furthermore, the company commits to increasing its annual sourcing of renewable electricity from 11% in FY2019 to 80% by FY2025 and 100% by FY2030. Sanofi also targets a 30% reduction in absolute Scope 3 GHG emissions from specific categories (purchased goods and services, capital goods, fuel and energy related activities, upstream transportation and distribution, waste generated in operations, business travel and employee commuting) by FY2030 from a FY2019 base year. For the long term, Sanofi commits to reducing absolute Scope 1, 2, and 3 GHG emissions by 90% by FY2045 from a FY2019 base year. Sanofi has also communicated an ambition to achieve carbon neutrality by 2030 across its entire value chain and joined the UN's 'Race to Zero' initiative.